Flow-cytometric method for the quantitation of the Fc function of intravenous immunoglobulin preparations

Vox Sanguinis

Volumn 78, Issue 3, 2000, Pages 185-193

  Ramasamy, Indra ^a   Tran, Em ^a   Charnock, Alison ^a   Farrugia, Albert ^a  

^a THERAPEUTIC GOODS ADMINISTRATION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DITHIOTHREITOL; FC RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTRAGRAM;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG STORAGE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEASUREMENT; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; REPRODUCIBILITY;

EID: 0034016697     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031178     Document Type: Article

References (33)

1. Committee for proprietary medicinal products: Notes for guidance on core spc for human normal immunoglobulin (i.v.). Publication No: CPMP/BPWP/859/95.
2. Van der Meche FGA, Schmitz PIM: A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-1129.
3. Dalakas MC, Illa I, Dambrosia JM, Shawke A, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S: A controlled trial of high dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329:1993-2000.
4. Dwyer JM: Manipulating the immune system with immuneglobulin. N Engl J Med 1992; 326:107-116.
5. Ballow M: Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue disease. Cancer 1991;68:1430-1436.
6. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB: Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia. Am J Haematol 1993;44: 237-242.
7. Herrod HG: Use of intravenous immunoglobulin (IVIG) therapy in adults. Allergy Proc 1994;15:309-312.
8. Mouthon L, Piketty C, Kazatchkne MD: Immunomodulation of autoimmune and systemic inflammatory disease with intravenous immunoglobulin. Vox Sang 1994;67:53-59.
9. Hässig A: Intravenous immunoglobulins: Pharmacological aspects and therapeutic use. Vox Sang 1986;51:10-17.
10. Prince AM, Horowitz, B, Horowitz MS, Zang E: The development of virus free labile blood derivatives - a review. Eur J Epidemiology 1987;3:103-118.
11. Armstrong-Fisher SS, Sweeney GM, Greiss MA, Urbaniak SJ: Functional assessment of therapeutic anti-D immunoglobulin using Fc mediated assays. Transfus Med 1995;5:21-29.
12. Ducrot T, Beliard R, Glacet A, Klein P, Harbonnier S, Benmostefa N, Bourel D: Use of the DAF assay to assess the functional properties of polyclonal and monoclonal RhD antibodies. Vox Sang 1996;71:30-36.
13. Yang YHJ, Ngo C, Yeh IN, Uemura Y: Antibody Fc functional activity of intravenous immunoglobulin preparations treated with solvent-detergent for virus inactivation. Vox Sang 1994;67:337-344.
14. Gronski P, Kanzy EJ, Seiler FR: Measurement of Fc function of human immunoglobulin preparations. Pharmeuropa 1991;3:287-292.
15. Coiffier B, Haioun C, Kettere N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F: Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study. Blood 1998;92: 1927-1932.
16. Tam SH, Sassoli PM, Jordan RE, Nakada MT: Abciximab (Reopro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein Iib/IIIa and alpha(v) beta 3 integrins. Circulation 1998;98: 1085-1091.
17. Vaughn TJ, Osbourn JK, Tempest PR: Human antibodies by design. Nat Biotechnol 1998;16: 535-539.
18. Jones DH, Looney RJ, Anderson CL: Two distinct classes of IgG Fc receptors on a human monocyte cell line (U937) defined by difference in binding of murine IgG subclasses at low ionic strength. J Immunol 1985;135: 3348-3353.
19. Shopes B, Weetall M, Holowka D, Baird B: Recombinant human IgG1-murine IgG chimeric Ig. J Immunol 1990;145:3842-3848.
20. Partridge LJ, Woof JM, Burton DR: The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG. Mole Immunol 1986;23:1365-1372.
21. Koitschke R: Assessment of the Fc function in human immunoglobulins for intravenous administration. Infusionther Transfusionmed 1993;20:93-95.
22. Gessner JE, Heiken H, Tamm A, Schmidt RE: The IgG Fc receptor family. Ann Hematol 1998;76:231-248.
23. van den Herik-Oudijk IE, Verbeek SJ, Capel PJA, van de Winkel JGJ: FcγR on mononuclear cells; in van de Winkel JGJ, Capel PJA (eds): Human IgG Receptors. Austin, Landes, 1996.
24. Anderson CL, Shen L, Eicher DM, Wewers MD, Gill JK: Phagocytosis mediated by three distinct Fcγ receptors classes on human leukocytes. J Exp Med 1990;171:1333-1345.
25. Harrison PT, Davis W, Norman JC, Hockaday AR, Allen JM: Binding of monomeric immunoglobulin G triggers FcγRl mediated endocytosis. J Biol Chem 1994;269:24396-24402.
26. Gosselin EJ, Wardwell K, Gosselin DR, Alter N, Fisher JL, Guyre PM: Enhanced antigen presentation using human FcγR receptor (monocyte/macrophage) specific immunogens. J Immunol 1992;11:3477-3481.
27. Fanger MW, Shen L, Graziano RF, Guyre PM: Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989;10:92-99.
28. Law DTS, Painter RH: An examination of the structural and biological properties of three intravenous immunoglobulin preparations. Mol Immunol 1986;23:331-338.
29. Yu AL, Uttenreuther-Fischer MM, Huang CS, Tsui CC, Gillies SD, Reisfeld RA, Kung FH: Phase I trial of a human mouse chimeric anti-disialoganglioside monoclonal antibody ch 14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 1998;16: 2169-2180.
30. Dickman S: Antibodies stage a comeback in cancer treatment. Science 1998;280:1196-1197.
31. Adgey AA: An overview of the results of clinical trials with glycoprotein Iib/IIIa inhibitors. Am Heart J 1998;135:S43-S55.
32. Shopes B, Weetall M, Holowka D, Baird B: Recombinant human IgG-1 murine IgE chimeric Ig. J Immunol 1990;145:3842-3848.
33. Partridge LG, Woof JM, Jeffereis R, Burton DR: The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG. Mol Immunol 1986;23:1365-1372.